GLP-1s Tied to Weight Loss in Real-World Rheumatologic Care
Semaglutide and tirzepatide use is rising among patients with rheumatic and musculoskeletal diseases and is linked to meaningful 1-year weight loss, especially in tirzepatide users. Medscape Medical News source https://www.medscape.com/viewarticle/glp-1s-tied-weight-loss-real-world-rheumatologic-care-2026a1000gmt?src=rss